Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period

Clinical and Experimental Ophthalmology

Volumn 41, Issue 2, 2013, Pages 159-166

  Gunn, David J ^a   Cartwright, David W ^b,c   Yuen, Sonia A ^a   Gole, Glen A ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Extremely premature; Laser therapy; Neonatal intensive care; Retinopathy of prematurity

Indexed keywords

ANTIBIOTIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; STEROID;

ARTICLE; EXTREMELY PREMATURE INFANT; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INFANT; LASER DIODE THERAPY; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; REFRACTION ERROR; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SCREENING TEST; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; LASER COAGULATION; LASERS, SEMICONDUCTOR; LONGITUDINAL STUDIES; MALE; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84875518857     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02839.x     Document Type: Article

References (50)

1. Early Treatment for Retinopathy of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121: 1684-94.
2. Clark D, Mandal K. Treatment of retinopathy of prematurity. Early Hum Dev 2008; 84: 95-9.
3. Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10years: part 2. Refractive outcome. Ophthalmology 2002; 109: 936-41.
4. Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10years: part 1. Visual function and structural outcome. Ophthalmology 2002; 109: 928-34; discussion 35.
5. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 2001; 132: 76-80.
6. Yang CM, Chen MS, Tsou Yau KI, Teng RJ. Comparison of cryotherapy and laser photocoagulation in stage III retinopathy of prematurity. J Formos Med Assoc 1997; 96: 734-9.
7. Fanaroff AA, Stoll BJ, Wright LL etal. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196: 147 e1-8.
8. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364: 603-15.
9. Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE. Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2013; 98: F170-4.
10. Gunn DJ, Cartwright DW, Gole GA. Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol 2012; 40: 93-9.
11. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984; 102: 1130-4.
12. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123: 991-9.
13. Lee GA, Hilford DJ, Gole GA. Diode laser treatment of pre-threshold and threshold retinopathy of prematurity. Clin Experiment Ophthalmol 2004; 32: 164-9.
14. Axer-Siegel R, Bourla D, Friling R etal. Intraocular pressure variations after diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 2004; 111: 1734-8.
15. Lee GA, Lee LR, Gole GA. Angle-closure glaucoma after laser treatment for retinopathy of prematurity. J AAPOS 1998; 2: 383-4.
16. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 2005; 115: 997-1003.
17. Quinn GE, Gilbert C, Darlow BA, Zin A. Retinopathy of prematurity: an epidemic in the making. Chin Med J (Engl) 2010; 123: 2929-37.
18. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84: 77-82.
19. Gilbert C, Fielder A, Gordillo L etal. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005; 115: e518-25.
20. Akkoyun I, Oto S, Yilmaz G etal. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10: 449-53.
21. Chen M, Citil A, McCabe F etal. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology 2010; 99: 125-32.
22. Fortes Filho JB, Eckert GU, Valiatti FB, Dos Santos PG, da Costa MC, Procianoy RS. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol 2010; 248: 893-900.
23. Karna P, Muttineni J, Angell L, Karmaus W. Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 2005; 5: 18.
24. Austeng D, Kallen KB, Ewald UW, Jakobsson PG, Holmstrom GE. Incidence of retinopathy of prematurity in infants born before 27weeks' gestation in Sweden. Arch Ophthalmol 2009; 127: 1315-9.
25. Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005; 115: 990-6.
26. Markestad T, Kaaresen PI, Ronnestad A etal. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005; 115: 1289-98.
27. Weber C, Weninger M, Klebermass K etal. Mortality and morbidity in extremely preterm infants (22 to 26weeks of gestation): Austria 1999-2001. Wien Klin Wochenschr 2005; 117: 740-6.
28. Paysse EA, Lindsey JL, Coats DK, Contant CF Jr, Steinkuller PG. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J AAPOS 1999; 3: 234-40.
29. Al-Ghamdi A, Albiani DA, Hodge WG, Clarke WN. Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation. Can J Ophthalmol 2004; 39: 521-5.
30. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106: 659-71.
31. Slidsborg C, Olesen HB, Jensen PK etal. Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996 2005): is the incidence increasing? Pediatrics 2008; 121: 97-105.
32. Austeng D, Kallen KB, Ewald UW, Wallin A, Holmstrom GE. Treatment for retinopathy of prematurity in infants born before 27weeks of gestation in Sweden. Br J Ophthalmol 2010; 94: 1136-9.
33. Axer-Siegel R, Maharshak I, Snir M etal. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina 2008; 28: 839-46.
34. DeJonge MH, Ferrone PJ, Trese MT. Diode laser ablation for threshold retinopathy of prematurity: short-term structural outcome. Arch Ophthalmol 2000; 118: 365-7.
35. Dhawan A, Dogra M, Vinekar A, Gupta A, Dutta S. Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2008; 45: 356-61.
36. Essex RW, Carden SM, Elder JE. Two-year results of laser treatment for retinopathy of prematurity at a single neonatal intensive care unit. Clin Experiment Ophthalmol 2005; 33: 390-4.
37. Forouchi E, Gunn DJ. Some effects of metal ions on the estimation of reducing sugars in biological media. Biotechnol Bioeng 1983; 25: 1905-11.
38. McEniery CM, Bolton CE, Fawke J etal. Cardiovascular consequences of extreme prematurity: the EPICure study. J Hypertens 2011; 29: 1367-73.
39. Good WV, Hardy RJ, Dobson V etal. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010; 128: 663-71.
40. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995; 92: 905-9.
41. Sato T, Kusaka S, Shimojo H, Fujikado T. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 2009; 116: 1599-603.
42. Young TL, Anthony DC, Pierce E, Foley E, Smith LE. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS 1997; 1: 105-10.
43. Gonzalez VH, Giuliari GP, Banda RM, Guel DA, Wingard M. Confluent laser photocoagulation for the treatment of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2010; 47: 81-5; quiz 6-7.
44. Rezai KA, Eliott D, Ferrone PJ, Kim RW. Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol 2005; 123: 621-6.
45. Banach MJ, Ferrone PJ, Trese MT. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 2000; 107: 324-7; discussion 8.
46. Lepore D, Molle F, Pagliara MM etal. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology 2011; 118: 168-75.
47. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR. The EPICure study: associations and antecedents of neurological and developmental disability at 30months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2005; 90: F134-40.
48. McLoone EM, O'Keefe M, McLoone SF, Lanigan BM. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity. J AAPOS 2006; 10: 454-9.
49. Nissenkorn I, Yassur Y, Mashkowski D, Sherf I, Ben-Sira I. Myopia in premature babies with and without retinopathy of prematurity. Br J Ophthalmol 1983; 67: 170-3.
50. Quinn GE, Dobson V, Kivlin J etal. Prevalence of myopia between 3months and 5 1/2years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1998; 105: 1292-300.